Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04091438
Recruitment Status : Completed
First Posted : September 16, 2019
Last Update Posted : March 8, 2021
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 25, 2020
Actual Study Completion Date : November 25, 2020